ALLIANCEBERNSTEIN L.P. - VIR BIOTECHNOLOGY INC ownership

VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 119 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of VIR BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$27,151,768
-59.8%
2,897,734
+5.3%
0.01%
-57.1%
Q2 2023$67,499,593
+5.5%
2,751,716
+0.1%
0.03%
+3.7%
Q1 2023$63,965,623
+7.4%
2,748,845
+16.8%
0.03%0.0%
Q4 2022$59,576,171
+32.4%
2,353,859
+0.8%
0.03%
+22.7%
Q3 2022$45,006,000
-36.9%
2,334,318
-16.6%
0.02%
-33.3%
Q2 2022$71,330,000
-10.3%
2,800,537
-9.4%
0.03%
+6.5%
Q1 2022$79,503,000
-27.5%
3,091,105
+17.9%
0.03%
-20.5%
Q4 2021$109,731,000
+18.0%
2,620,753
+22.6%
0.04%
+5.4%
Q3 2021$93,024,000
-7.2%
2,137,492
+0.8%
0.04%
-7.5%
Q2 2021$100,282,000
+8.7%
2,121,026
+17.9%
0.04%0.0%
Q1 2021$92,223,000
+16.1%
1,798,779
-39.4%
0.04%
+8.1%
Q4 2020$79,451,000
+11.2%
2,966,806
+42.5%
0.04%
-2.6%
Q3 2020$71,455,000
-10.0%
2,081,425
+7.4%
0.04%
-19.1%
Q2 2020$79,436,000
+10534.0%
1,938,872
+8793.9%
0.05%
+4600.0%
Q1 2020$747,00021,8000.00%
Other shareholders
VIR BIOTECHNOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,559,142$36,281,23432.04%
SB INVESTMENT ADVISERS (UK) LTD 18,319,938$426,304,9573.50%
Zebra Capital Management LLC 27,110$6313.15%
Avidity Partners Management LP 1,640,200$38,167,4541.27%
Sofinnova Investments, Inc. 657,559$15,301,3980.98%
DCF Advisers, LLC 62,000$1,442,7400.88%
SECTOR GAMMA AS 145,545$3,386,8320.82%
Temasek Holdings (Private) Ltd 5,814,972$135,314,3980.80%
BRAIDWELL LP 604,036$14,055,9180.46%
SummerHaven Investment Management, LLC 26,045$606,0670.35%
View complete list of VIR BIOTECHNOLOGY INC shareholders